Modifying ART in the Presence of Hyperlipidemia: Using HIV-ASSIST - a podcast by Clinical Care Options

from 2023-12-12T21:14:12.402079

:: ::

In this episode, Maunank Shah, MD, PhD, discusses using HIV-ASSIST to optimize treatment for both HIV and hyperlipidemia. Listen as he covers:

Hyperlipidemia and cardiovascular disease risk among people living with HIV
Recommendations for lipid screening for people living with HIV
Using HIV-ASSIST to support ART treatment decisions for people living with HIV with comorbidities
How HIV-ASSIST prioritizes certain ART agents in the setting of hyperlipidemia, including:
- Deciding between bictegravir, doravirine, dolutegravir, raltegravir, and rilpivirine vs boosted protease inhibitors, including darunavir
- Deciding between tenofovir disoproxil fumarate and tenofovir alafenamide or abacavir
How HIV-ASSIST incorporates drug‒drug interaction data from the University of Liverpool HIV Drug Interactions Checker and the DHHS guidelines when considering the use of statin therapy with ART
How HIV-ASSIST further incorporates drug resistance data from the Stanford HIV Drug Resistance Database

Maunank Shah, MD, PhD
Associate Professor
Infectious Diseases
Johns Hopkins University
Baltimore, Maryland

Link to full program: bit.ly/3pwaH2Y